WideCells Group said that in the almost one year since listing it has made astronomical progress in building a revenue generative end-to-end stem cell support services company.
"Testament to this is the recognition we received from DISRUPT 100, an annual index celebrating the businesses with the most potential to influence, change or create new global markets, where WideCells Group was ranked as the 21st most disruptive company globally," said CEO Joao Andrade.
In an AGM statement, Andrade said the business currently had three primary divisions, being CellPlan Ltd, WideCells Group Science and WideAcademy, with four potential revenue streams.
"With revenues now being received and set to increase from WideCells, from both storage and research, and the launch of our core stem cell insurance product in June 2017 creating a third, we have reached an inflection point as we enter a new and significant period of growth."
At 9:50am: (LON:WDC) Widecells Group Plc Ord Gbp0.0025 share price was +0.25p at 14p